Steven Pfanstiel, CFO AND COO at MARINUS PHARMACEUTICALS, INC. (MRNS), sold 4,657 shares at $1.13 ($5K) on 2024-08-05, disclosed to the SEC on 2024-08-07.
Scheduled sale ($5k) by CFO AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRNS | SELL | 2024-02-21 | $31K | — | Filing → |
| MRNS | SELL | 2023-08-08 | $27K | — | Filing → |